Quality Agreements With Contract Manufacturing Organizations (CMOs)
Source: MasterControl, Inc.
By James Jardine, GxP Lifeline Editor, MasterControl
The rapid pace of innovation and growing competition in the life sciences sector has prompted many companies to shift toward asset-light operational models, relying more heavily on partnerships with contract manufacturing organizations (CMOs). As this approach gains momentum, it is essential for both CMOs and the companies they serve to maintain strict adherence to the U.S. Food and Drug Administration’s (FDA) current good manufacturing practice (cGMP) regulations. Explore seven essential details to include in an effective CMO quality agreement.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
MasterControl, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more